Ignite Creation Date:
2024-05-06 @ 2:56 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02161718
Status:
COMPLETED
Last Update Posted:
2021-10-08
First Post:
2014-05-28
Brief Title:
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
Sponsor:
Alkermes Inc
Organization:
Alkermes Inc
Study Overview
Official Title:
A Phase 2 Efficacy Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Status:
COMPLETED
Status Verified Date:
2021-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This double-blind randomized study will evaluate the efficacy safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder AUD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None